Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_assertion type Assertion NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_head.
- NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_assertion description "[Our results suggest that (a) deficiency in MIC-NKG2D immune surveillance may contribute to prostate cancer progression, (b) sMIC may be a novel biomarker for prostate cancer, and (c) using cytokines to restore MIC-NKG2D-mediated immunity may have clinical significance for prostate cancer in cell-based adaptive immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_provenance.
- NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_assertion evidence source_evidence_literature NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_provenance.
- NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_assertion SIO_000772 15314693 NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_provenance.
- NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_assertion wasDerivedFrom befree-2016 NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_provenance.
- NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_assertion wasGeneratedBy ECO_0000203 NP456277.RA4JpZxigQF9XW5Rv-WWAD3-B0a6CzZLK_Ali3uCi42yw130_provenance.